• Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Author J.M. Lanham

J.M. Lanham is an American author of science fiction, suspense, thrillers, and supernatural fiction.

  • All Books
  • Blog
  • About the Author
  • Contact

science fiction

The R.E.M. Effect: Taking Pre-Orders Through November 14th

November 10, 2016 By John

Less than one week before The R.E.M. Effect hits the digital shelves!

Tuesday, November 15th is the Kindle release date for The R.E.M. Effect (paperback is currently scheduled for the 22nd).

If sci-fi thrillers involving Big Pharma, sleeping pills, coverups and conspiracies sound like your type of literary action, then you don’t want to miss this!

In the meantime, you can preorder your digital copy for Kindle by checking out my Amazon page here.

Since this post is already the most shameless of plugs, I might as well encourage you to sign up for my weekly email club. The current format shoots out a weekly email on Fridays titled Science Break Friday. The emails cover interesting topics in the world of medicine and technology, as well as links to outside resources like articles and videos.

The coolest part of this year’s editorial calendar for Science Break Friday is that each topic ties into The R.E.M. Effect in one way or another. A lot of research went into writing this novel, and I wanted to share that research and background with interested readers.

So if you have a minute to kill, feel free to browse around the site and see if there’s anything you like (or don’t like). I’m always open to suggestions, so if there’s a blog post you would like to see in the future, or a topic you would like to discuss, just drop me a line in the inbox and I’ll be in touch.

And if you’ve made it this far, you deserve a big THANK YOU for your interest in The R.E.M. Effect.

Have a great day!

–  J.M. Lanham

 

 

Filed Under: Uncategorized Tagged With: REM, sci-fi, sci-fi novel, sci-fi thriller, science fiction, suspense, The R.E.M. Effect, The REM Effect, thriller

A Look at the Drug Behind The REM Series

January 14, 2016 By John

Trouble sleeping? Then Asteria Pharmaceuticals has the pill for you.

Advertisement for Ocula featuring a sleeping statue, making insomnia a relic of the past.
Turning insomnia into a relic of the past.

It’s called Ocula, and it’s the pharmaceutical breakthrough of the 21st century. No longer are patients bound by unreliable sleeping medications that only treat the symptoms of insomnia and sleeplessness.

With Ocula, patients are treated at the source of their insomnia, freeing them to experience the perfect eight-hour sleep cycle—guaranteed.

How is this possible? Because Ocula is the first drug in the history of pharmacology to use gene-silencing technology—also known as antisense therapy—to inhibit the genes responsible for chronic sleep disorders.

By binding to your body’s RNA, and then blocking the production of faulty proteins, Ocula keeps the genes linked to insomnia and sleeplessness from reproducing.

The result? A genetic sequence that defaults to the human body’s natural eight-hour sleep cycle.

Say goodbye to tossing and turning through sleepless nights . . . relying on addictive sleeping pills that leave you feeling groggy and tired the next day . . . worrying about trudging through another day at work without sleep.

Isn’t it time you got the quality shut-eye you deserve?

Well now you can. So if you can’t sleep, don’t worry—Asteria Pharmaceuticals has a pill for that.

Ocula: Rest Easy with Us

 

Be sure to check out J.M. Lanham’s pharmaceutical/sci-fi thriller, The R.E.M. Effect, available now on Amazon.com.

ORDER YOUR COPY NOW! 

Filed Under: Behind the Scenes of The R.E.M. Effect Tagged With: Asteria Pharmaceuticals, Big Pharma, Big Pharma thriller, ebook, J.M. Lanham, Ocula, pharmaceutical thriller, R.E.M. Effect, REM book, REM Effect, sci-fi thriller, science fiction

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3

© Copyright 2026 J.M. Lanham · All Rights Reserved · Privacy Policy · Admin


DISCLOSURE: As an Amazon Associate I earn from qualifying purchases, meaning that, at no additional cost to you, I may earn a commission if you click through and make a purchase. Thank you for supporting indie authors!